$VICR

VINCIARELLI PATRIZIO sold $141K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 420 shares of VICOR CORP (VICR) at $335.76 ($0.14M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published May 29, 2026, 6:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 7:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because the sale is explicitly under Rule 10b5-1, it is generally treated as routine compliance rather than a fresh negative fundamental signal; any trading impact is more likely sentiment/positioning than valuation.

02

Market read

Disclosure may cause minor, short-term sentiment noise, but lacks new company-specific fundamental information.

03

What to watch

The article doesn’t state total planned volume, remaining 10b5-1 schedule, or whether sales cluster around specific events—those details matter for interpreting signal strength.

Relevance 6/10Novelty 3/10Timing: Filed today; sale executed 2026-05-28 (420 shares at ~$335.76).

Background

This is an SEC Form 4 insider transaction disclosure for Vicor Corp, reporting an open-market sale by the CEO/Chairman/10% owner under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Vinciareli Patrizio (VICR Chairman/CEO/10% owner) sold 420 shares in an open-market transaction filed as an SEC Form 4.

Expected impact

Likely limited immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing specifies a pre-arranged Rule 10b5-1 plan, reducing the likelihood the sale reflects new negative information.

Market effects

Minimal—single-company insider transaction without accompanying operational/regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with periods of weaker outlook or liquidity needs; traders may watch for follow-on sales.

Key entities

  • VICOR CORP

    Subject of the insider transaction disclosure (SEC Form 4).

  • VINCIARELLI PATRIZIO

    Chairman and CEO; reported open-market sale of 420 shares under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: